Burning Rock Biotech Limited
BNR
$2.90
-$0.04-1.36%
NASDAQ
| 12/31/2024 | 12/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -2.51% | -4.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.51% | -4.78% | |||
| Cost of Revenue | -1.02% | 3.51% | |||
| Gross Profit | -3.11% | -8.80% | |||
| SG&A Expenses | 2.87% | -5.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.84% | -5.90% | |||
| Operating Income | -20.69% | 6.69% | |||
| Income Before Tax | -112.73% | 7.38% | |||
| Income Tax Expenses | 2,528.83% | 138.81% | |||
| Earnings from Continuing Operations | -126.33% | 7.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -126.33% | 7.01% | |||
| EBIT | -20.69% | 6.69% | |||
| EBITDA | -490.07% | 9.92% | |||
| EPS Basic | -126.05% | 7.07% | |||
| Normalized Basic EPS | -14.24% | 7.45% | |||
| EPS Diluted | -126.05% | 7.07% | |||
| Normalized Diluted EPS | -14.24% | 7.45% | |||
| Average Basic Shares Outstanding | 0.13% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.14% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||